Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukinori Ozaki

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 10, 2023
[Challenges to International Collaborative Clinical Research and Approval Disparities]Yukinori Ozaki, Toshimi Takano
Japanese Journal of Clinical Oncology|July 9, 2025
Current status and perspective of ctDNA-based MRD testing in breast cancer: a systematic reviewYukinori Ozaki, Hiroji Iwata
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 26, 2025
[Current Status of ctDNA-Based MRD Testing in Breast Cancer]Yukinori Ozaki, Hiroji Iwata
Yeast (Chichester, England)|April 15, 2026
Glucose Restriction Extends Chronological Lifespan of Budding Yeast by Avoiding Commonly Used Auxotrophic Marker Nutrient StarvationYukinori Ozaki, Taku Ozaki, Qiu-Mei Zhang-Akiyama
American Journal of Cancer Research|November 16, 2023
IL25<sup>+</sup> macrophages are a key determinant of treatment resistance of IL17RB<sup>+</sup> breast cancerYukinori Ozaki, Keiichi Kinowaki, Hidetaka Kawabata, et al.
Cancers|January 11, 2022
Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the LiteratureYukinori Ozaki, Sakiko Miura, Ryosuke Oki, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2026
A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor TreatmentYosuke Aoyama, Yurie Haruyama, Yukinori Ozaki, et al.
Cancers|February 4, 2021
Targeting Oncoimmune Drivers of Cancer MetastasisChie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, et al.
Future Oncology (London, England)|June 8, 2026
Real-world data on patients with HR+, HER2- early breast cancer prescribed with abemaciclib adjuvant therapy for 2 years in JapanYukinori Ozaki, Moemi Urano, Nobuyuki Sekine, et al.
Cancer Medicine|November 25, 2024
Proposal for Managing Cancer-Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of TreatmentYoshinori Saeki, Yukiyoshi Sumi, Yukinori Ozaki, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 10, 2023
[Challenges to International Collaborative Clinical Research and Approval Disparities]Yukinori Ozaki, Toshimi Takano
Japanese Journal of Clinical Oncology|July 9, 2025
Current status and perspective of ctDNA-based MRD testing in breast cancer: a systematic reviewYukinori Ozaki, Hiroji Iwata
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 26, 2025
[Current Status of ctDNA-Based MRD Testing in Breast Cancer]Yukinori Ozaki, Hiroji Iwata
Yeast (Chichester, England)|April 15, 2026
Glucose Restriction Extends Chronological Lifespan of Budding Yeast by Avoiding Commonly Used Auxotrophic Marker Nutrient StarvationYukinori Ozaki, Taku Ozaki, Qiu-Mei Zhang-Akiyama
American Journal of Cancer Research|November 16, 2023
IL25<sup>+</sup> macrophages are a key determinant of treatment resistance of IL17RB<sup>+</sup> breast cancerYukinori Ozaki, Keiichi Kinowaki, Hidetaka Kawabata, et al.
Cancers|January 11, 2022
Neuroendocrine Neoplasms of the Breast: The Latest WHO Classification and Review of the LiteratureYukinori Ozaki, Sakiko Miura, Ryosuke Oki, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2026
A Case of Transient ACTH and Cortisol Suppression Caused by Dexamethasone Mouthwash during Immune Checkpoint Inhibitor TreatmentYosuke Aoyama, Yurie Haruyama, Yukinori Ozaki, et al.
Cancers|February 4, 2021
Targeting Oncoimmune Drivers of Cancer MetastasisChie Kudo-Saito, Yukinori Ozaki, Hiroshi Imazeki, et al.
Future Oncology (London, England)|June 8, 2026
Real-world data on patients with HR+, HER2- early breast cancer prescribed with abemaciclib adjuvant therapy for 2 years in JapanYukinori Ozaki, Moemi Urano, Nobuyuki Sekine, et al.
Cancer Medicine|November 25, 2024
Proposal for Managing Cancer-Related Insomnia: A Systematic Literature Review of Associated Factors and a Narrative Review of TreatmentYoshinori Saeki, Yukiyoshi Sumi, Yukinori Ozaki, et al.
Pageof 7